Tian focuses her practice on patent preparation, patent prosecution and IP due diligence in corporate transactions. She is experienced in working with diverse technologies in the life sciences sector, including antibodies, biologics, cancer therapeutics and next-generation sequencing technologies.
Immunology Company argenx Announces $1.27 Billion Global Offering
July 26, 2023
Cooley advised J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities and TD Cowen, representatives of the several underwriters, in the $1.27 billion follow-on offering by argenx SE, a global immunology company.
